Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback